[Anti-erythrocyte and anti-HLA immunization in hemoglobinopathies].

Area of Science:

• Hematology
• Immunology
• Transfusion Medicine

Context:

• Hemoglobinopathies, including sickle cell disease and thalassemia syndromes, often require chronic blood transfusions.
• Transfusion-dependent patients are at increased risk of alloimmunization and autoimmunization.
• Evaluating immunization rates is crucial for ensuring transfusion safety in these vulnerable populations.

Purpose:

• To assess the prevalence of anti-erythrocyte and anti-HLA immunization in patients with hemoglobinopathies.
• To identify risk factors associated with anti-erythrocyte autoimmunization.
• To determine the relationship between anti-erythrocyte and anti-HLA immunization.

Summary:

• A cross-sectional study of 83 hemoglobinopathy patients found high rates of anti-erythrocyte alloimmunization (10.84%) and anti-HLA immunization (31.6%).
• Autoimmunization rates were significantly higher in thalassemia syndromes (41.46%) compared to sickle cell disease (7.14%).
• Younger age at transfusion and higher transfusion volume were linked to increased anti-erythrocyte autoimmunization risk.

Impact:

• The findings underscore the significant risk of immunization in transfusion-dependent hemoglobinopathy patients.
• High immunization rates necessitate the development and implementation of preventive strategies to enhance blood product safety.
• Further research may explore specific interventions to mitigate alloimmunization and autoimmunization in this cohort.